Amicus Therapeutics, Inc. (FOLD)
14.30
+0.02
(+0.14%)
USD |
NASDAQ |
Feb 06, 16:00
14.29
-0.01
(-0.07%)
After-Hours: 20:00
Amicus Therapeutics SG&A Expense (TTM) : 353.07M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 973.41M |
| CorMedix, Inc. | 75.56M |
| Krystal Biotech, Inc. | 136.75M |
| MannKind Corp. | 195.42M |
| Keros Therapeutics, Inc. | 45.77M |